Taiyao Chemical, a major manufacturer of active pharmaceutical ingredients (APIs), announced its February 2026 monthly revenue of NT$233 million, a 20.5% year-on-year decrease. This figure reflects changes in customer order patterns and product mix. The company has long focused on areas such as cholesterol reduction and Vitamin D.
Company Code: 4746
Company Name: Taiyao
Industry: Biotechnology and Medical Industry
Data Month: 2026-02
Current Month Revenue: NT$232,724 thousand (NT$233 million)
Year-on-year change from same month last year: -20.5%
FACT BOX
- Source: PR Times
- Category: 其他